Commercial updates included first patient scans at the initial Nanox Imaging Network site in Philadelphia, insurer reimbursements for scans, and 10 U.S. distribution partners.
Quarterly results and cash position
Nano-X Imaging revenue rose 37% year over year to USD 4.2 million, boosted by Nanox Health IT consolidation, which added USD 0.9 million.
GAAP net loss widened to USD 55.5 million, reflecting a USD 40.7 million intangible-asset impairment tied to the AI solutions unit.
Adjusted EBITDA loss increased to USD 11.3 million from the year-ago quarter.
Cash and cash equivalents fell to USD 31.4 million at June 30, 2026; it raised USD 8.5 million post-quarter-end.
NNOX•
